Multidisciplinary research is generally set-up to integrate various indications with platforms for diagnostics, drugs, devices, and data. However, to ensure successful translation into meaningful medical areas, the research center will form agile project-related teams with external indication-specific partners. These partners will include the regionally leading clinics and research teams in societies’ key indications. This ensures that necessary data will be available and accessible, developments are driven by real-world needs, and that results are quickly elevated to patient care.
The COVID-19 pandemic has clearly shown the need for integrated pipelines to accelerate research and translation. In pandemics, the team’s approaches could predict future virus mutations to ensure the most sustainable vaccine development. The Center for Medicine Innovation’s unique set-up will allow bringing drug design research and small-batch production into stage 1 clinical trials.
Our device development up to tested and certified prototypes will enable us to provide smart hardware and drive remote medicine innovation. Employing our research, intelligent, lightweight devices will utilize the latest multimodal sensing, will provide measurements that are interpreted with the full power of medical knowledge and AI remotely, and will deliver reliable feedback to doctors and patients in no time.
The center’s set-up will allow for a seamless continuation of research into economic cycles for corporates and startups. By integrating the new center with existing research institutes in Leipzig, we will not only ensure the lasting and sustainable transfer of innovation but also complement existing competencies. Through that, the center provides an efficient value chain in terms of cost, information flow, and training, maximizing the impact of limited resources, with intellectual property, market-ready prototypes, and human resources ready to be translated to production and health care routine.